Gerhard I, Runnebaum B
Biol Res Pregnancy Perinatol. 1984;5(4):157-73.
In view of still unsolved problems concerning disturbances in early pregnancy, the efficacy of various substances with regard to endocrine systems in the first trimester of pregnancy has been investigated. Seventy-five women, who had been referred to our hospital for an authorized termination of pregnancy during weeks 7-9 of gestation, and 6 women between weeks 10 and 16 of gestation volunteered to take part in the study. After single administration of the test substances, blood was drawn from an indwelling catheter with one group of patients at hourly intervals over an 8-hour period, while with all other patients this was done at 3-hourly intervals over a 24-hour period. In all samples beta-HCG, progesterone (P), estradiol-17 beta (E2), and 17 alpha-hydroxyprogesterone (17-OHP) were determined. The following substances were studied in detail: HCG, allylestrenol, 17-hydroxyprogesterone caproate, tamoxifene, R 5020, betamethasone, and dehydroepiandrosterone sulfate (DHAS). Two hundred and seventy-one women with imminent abortion were either treated with allylestrenol (n = 130) or simple clinotherapy and no medication (n = 141). One hundred and two women had a miscarriage, while 168 carried to term. The serum concentrations of beta-HCG, P, E2 and estriol (E3) were determined serially. Twelve women with a history of repeated miscarriages were treated with vaginal progesterone suppositories. Five of them experienced another miscarriage. The serum concentrations of beta-HCG and P were determined serially. It could be shown that diagnostics in early pregnancy have been complemented by assessment of the E2-increase after DHAS loading. Maternal serum concentrations were not affected by administration of HCG and various progestational agents including allylestrenol. Only in the case of parenteral or vaginal application of progesterone could increased serum concentrations of this hormone be demonstrated. Progesterone substitution in early pregnancy may, therefore, be chosen under special conditions as possible therapeutic procedure.
鉴于早期妊娠相关问题仍未解决,对多种物质在妊娠头三个月对内分泌系统的作用效果进行了研究。75名在妊娠7至9周被转诊至我院进行合法终止妊娠的女性,以及6名妊娠10至16周的女性自愿参与了该研究。单次给予受试物质后,一组患者通过留置导管每小时采血一次,持续8小时,而其他所有患者则每3小时采血一次,持续24小时。在所有样本中测定了β-人绒毛膜促性腺激素(β-HCG)、孕酮(P)、雌二醇-17β(E2)和17α-羟孕酮(17-OHP)。详细研究了以下物质:人绒毛膜促性腺激素(HCG)、烯丙雌醇、己酸17-羟孕酮、他莫昔芬、R 5020、倍他米松和硫酸脱氢表雄酮(DHAS)。271名有流产先兆的女性,其中130名接受烯丙雌醇治疗,141名接受单纯临床治疗且未用药。102名女性流产,168名足月分娩。连续测定β-HCG、P、E2和雌三醇(E3)的血清浓度。12名有反复流产史的女性接受阴道孕酮栓剂治疗。其中5名再次流产。连续测定β-HCG和P的血清浓度。结果表明,通过评估DHAS负荷后E2的升高,早期妊娠诊断得到了补充。母体血清浓度不受HCG和包括烯丙雌醇在内的各种孕激素的给药影响。仅在肌肉注射或阴道应用孕酮的情况下,可证明该激素的血清浓度升高。因此,在特殊情况下,早期妊娠的孕酮替代可作为一种可能的治疗方法。